BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 21695171)

  • 1. Differential estrogen-regulation of CXCL12 chemokine receptors, CXCR4 and CXCR7, contributes to the growth effect of estrogens in breast cancer cells.
    Boudot A; Kerdivel G; Habauzit D; Eeckhoute J; Le Dily F; Flouriot G; Samson M; Pakdel F
    PLoS One; 2011; 6(6):e20898. PubMed ID: 21695171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scavenging of CXCL12 by CXCR7 promotes tumor growth and metastasis of CXCR4-positive breast cancer cells.
    Luker KE; Lewin SA; Mihalko LA; Schmidt BT; Winkler JS; Coggins NL; Thomas DG; Luker GD
    Oncogene; 2012 Nov; 31(45):4750-8. PubMed ID: 22266857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
    Wu W; Qian L; Chen X; Ding B
    Int J Clin Exp Pathol; 2015; 8(10):13217-24. PubMed ID: 26722521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.
    Hernandez L; Magalhaes MA; Coniglio SJ; Condeelis JS; Segall JE
    Breast Cancer Res; 2011; 13(6):R128. PubMed ID: 22152016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the CXCR7/CXCR4/CXCL12 axis in the malignant progression of human neuroblastoma.
    Liberman J; Sartelet H; Flahaut M; Mühlethaler-Mottet A; Coulon A; Nyalendo C; Vassal G; Joseph JM; Gross N
    PLoS One; 2012; 7(8):e43665. PubMed ID: 22916293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the CXCR4/CXCR7/CXCL12 Axis in Primary Desmoid Tumors.
    Baccalini EA; Renne SL; Colombo P; Pasqualini F; Quagliuolo VL; Cananzi FCM; Grizzi F; Borroni EM
    Anticancer Agents Med Chem; 2023; 23(20):2248-2253. PubMed ID: 36748819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCL12-CXCR4/CXCR7 axis contributes to cell motilities of oral squamous cell carcinoma.
    Chen N; Jiang X; Wang J; Wu T; Cheng B; Xia J
    Tumour Biol; 2016 Jan; 37(1):567-75. PubMed ID: 26232325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice.
    Saha A; Ahn S; Blando J; Su F; Kolonin MG; DiGiovanni J
    Cancer Res; 2017 Sep; 77(18):5158-5168. PubMed ID: 28687617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.
    Tarnowski M; Grymula K; Reca R; Jankowski K; Maksym R; Tarnowska J; Przybylski G; Barr FG; Kucia M; Ratajczak MZ
    Mol Cancer Res; 2010 Jan; 8(1):1-14. PubMed ID: 20068066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR.
    Circelli L; Sciammarella C; Guadagno E; Tafuto S; del Basso de Caro M; Botti G; Pezzullo L; Aria M; Ramundo V; Tatangelo F; Losito NS; Ieranò C; D'Alterio C; Izzo F; Ciliberto G; Colao A; Faggiano A; Scala S
    Oncotarget; 2016 Apr; 7(14):18865-75. PubMed ID: 26934559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis.
    Hall JM; Korach KS
    Mol Carcinog; 2013 Sep; 52(9):715-25. PubMed ID: 22549810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells.
    Ieranò C; Santagata S; Napolitano M; Guardia F; Grimaldi A; Antignani E; Botti G; Consales C; Riccio A; Nanayakkara M; Barone MV; Caraglia M; Scala S
    Cell Death Dis; 2014 Jul; 5(7):e1310. PubMed ID: 24991762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen Triggers the Pro-Migratory CXCL12/CXCR4 Axis in AR-Positive Breast Cancer Cell Lines: Underlying Mechanism and Possible Implications for the Use of Aromatase Inhibitors in Breast Cancer.
    Azariadis K; Kiagiadaki F; Pelekanou V; Bempi V; Alexakis K; Kampa M; Tsapis A; Castanas E; Notas G
    Cell Physiol Biochem; 2017; 44(1):66-84. PubMed ID: 29131020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR7 is not obligatory for CXCL12-CXCR4-induced epithelial-mesenchymal transition in human ovarian cancer.
    Zheng N; Liu W; Chen J; Li B; Liu J; Wang J; Gao Y; Shao J; Jia L
    Mol Carcinog; 2019 Jan; 58(1):144-155. PubMed ID: 30259564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioluminescent CXCL12 fusion protein for cellular studies of CXCR4 and CXCR7.
    Luker K; Gupta M; Luker G
    Biotechniques; 2009 Jul; 47(1):625-32. PubMed ID: 19594447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphenol AF stimulates transcription and secretion of C-X-C chemokine ligand 12 to promote proliferation of cultured T47D breast cancer cells.
    Li M; Han X; Gao W; Chen F; Shao B
    Toxicology; 2015 Dec; 338():30-6. PubMed ID: 26435001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.